Detalles de la búsqueda
1.
Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?
BMC Infect Dis
; 15: 178, 2015 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25888386
2.
Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study.
BMC Infect Dis
; 13: 293, 2013 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23809140
3.
Longitudinal study of body composition of 101 HIV men with lipodystrophy: dual-energy X-ray criteria for lipodystrophy evolution.
J Clin Densitom
; 13(2): 237-44, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20347366
4.
Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
Pharmacotherapy
; 26(2): 154-61, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16466321
5.
Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART.
AIDS
; 19(16): 1739-50, 2005 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-16227781
6.
Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.
J Clin Oncol
; 25(22): 3350-6, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17664482
7.
Virological and immunological effects of salvage therapy following treatment interruption and a shift in HIV-1 resistance genotype.
J Med Virol
; 68(3): 305-10, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12226815
Resultados
1 -
7
de 7
1
Próxima >
>>